# Enestia Belgium NV – FDA Inspection, Feb 20, 2026

Source: https://www.keypedia.com/records/fda_inspections/enestia-belgium-nv/f2af55d4-2946-4bf8-9f14-518ac6d5722c
Source feed: FDA_Inspections

> FDA inspection 1303534 of Enestia Belgium NV, February 20, 2026. 2 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1303534
- Company Name: Enestia Belgium NV
- Inspection Date: 2026-02-20
- Project Area: Vaccine, Allergenic, and Live Biotherapeutic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Office of Inspections and Investigations
- Citation Count: 2

## Related Documents

- FDA Inspection 1278760 - 2024-12-13
- [FDA Inspection 1250056 - 2024-09-19](https://www.keypedia.com/records/fda_inspections/enestia-belgium-nv/917c3608-36f0-4545-8b1f-144fc2530d7d)
- FDA Inspection 1039417 - 2017-12-15
- FDA Inspection 968494 - 2016-03-11

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/lewis-k-antwi/8ab4f1c7-8b5b-4556-98a4-6edc3bc49470)
- [Investigator](https://www.keypedia.com/people/peng-zhou/ce413ab5-8787-4012-bc8f-9ef55f2c3dc1)

Company: https://www.keypedia.com/companies/enestia-belgium-nv/a04913ee-f2a8-4712-9ab2-39a70a715210

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
